Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AGRYLIN safely and effectively. See full prescribing information for AGRYLIN. AGRYLIN® (anagrelide) capsules, for oral useInitial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
AGRYLIN is indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.
- generic_name
- anagrelide hydrochloride
- product_names
- anagrelide hydrochloride
- ndc
- 54092-063, 54092-063-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en